Published in Obesity and Diabetes Week, July 19th, 2004
In 2002, Eyetech licensed from Isis specific patents necessary to develop, manufacture, and commercialize Macugen. Under the terms of the agreement, Isis may earn additional milestone and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.